Разработка вирусной частицы HBV HBsAg

• 

  HBsAg VLP Developmen

  Yaohai is working to improve the immune system response by producing HBsAg VLPs. The immune system is an army of superheroes Бактериофаг Q VLP Производство living inside the body that fight off sickness. HBsAg VLPs can be a very powerful tool to halt the disease by educating the immune system to recognize and attack the HBV virus. And this is why Yaohai thinks their work with HBsAg VLPs is so important.

• 

  Unleashing the Potential of VLPs in HBV Therapy

  Successful vaccine development for other diseases using VLPs has already taken place. Now, Yaohai is investigating whether they can use VLPs to tackle HBV as well. The best potential uses of VLPs for protection against HBV are still being revealed through very important research they are conducting. This study is a significant step to pave the way toward the application of VLPs in disease treatment.

• 

  Advancements in HBV HBsAg VLP Developmen

  Yaohai continues to work diligently towards gaining more insight regarding HBsAg VLPs. They are learning new ways to make these pieces that make them heftier and more efficient. In this investigation, these VLPs Производство химерных вакцин VLP are challenged in animals and humans to assess their efficacy against HBV. Nevertheless, every breakthrough brings hope for better therapies and a solution for those afflicted by this virus.

Why choose Yaohai HBV HBsAg VLP Development?

• Надежная цепочка поставок и производственные возможности

  Yaohai Bio-Pharma, a top 10 producer of biological products, is a specialist in microbial fermentation. We have built an advanced facility that is equipped with advanced facilities as well as robust RD and manufacturing capabilities. Five drug substance production lines that are compliant with GMP standards for microbial purification and fermentation along with two automated fill and finishing lines for vials, cartridges and needles pre-filled are available. The scales for fermentation available are 100L, 500L, 1000L and 2000L. The filling volume ranges from 1ml to HBV HBsAg VLP Development. Syringes or cartridges pre-filled are filled with the equivalent of 1-3ml. Our cGMP-compliant production workshop ensures steady supply of clinical samples and commercial products. The bulk molecules produced in our factory can be shipped worldwide.

• Профессиональная экспертиза и обширный опыт

  HBV HBsAg VLP Development is a leading in microbial biologics CDMO. Our focus has been on microbial-produced vaccines and therapeutics that are suited for human, veterinary, as well as pet health management. We have the most cutting-edge RD platforms and manufacturing technology which cover the entire procedure beginning with the development of microbial strains and cell banking, to process and method development, to commercial and clinical production which ensures successful delivery of innovative solutions. Over time, we have accumulated vast knowledge of microbial-based bio processing. Over 200 projects have been successfully completed, and we assist our clients to comply with regulations like those of US FDA and EU EMA. We also help them to navigate Australia TGA and China NMPA. Our professional expertise and extensive experience allows us to quickly respond to market demands and provide bespoke CDMO services.

• Персонализация, эффективность и экономичность

  Yaohai Bio-Pharma has experience in the manufacture of biologics derived from microorganisms. We offer tailored RD solutions and manufacturing while minimizing the risk. We have worked with diverse methods, such as HBV HBsAg VLP Development of vaccines (including peptides), growth factors, hormones, and Cytokines. We specialized in multiple microbial hosts, including yeast extracellular and intracellular (yield up to 15 g/L) bacteria periplasmic secretion, soluble intracellular, and inclusion bodies (yield up to 10 grams/L). We also have a BSL-2 fermentation platform to create bacterial vaccines. We specialize in improving processes, increasing product yields, as well as reducing production costs. We have an efficient technology team that guarantees timely and quality project delivery. This allows us to deliver your exclusive products quicker to market.

• Система качества и соответствие глобальным нормативным требованиям

  Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates HBV HBsAg VLP Development as well as regulatory affairs. We have a quality management system which is in line with current GMP standards as well as global regulations. Our team of regulatory experts is proficient in global regulatory frameworks to accelerate biological launches. We ensure traceable production processes quality products, as well as complying with the rules of the US FDA and EU EMA. Australia TGA and China NMPA are also satisfied. Yaohai BioPharma has successfully passed the audit on site of the European Union's Qualified Person (QP) for our GMP quality system as well as our production facility. Furthermore, we have cleared the first certification audits of the ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.

Связанные категории товаров

• Продукция антигена HBV
• Разработка вирусной частицы HBV HBcAg

Не нашли то, что ищете?
Свяжитесь с нашими консультантами, чтобы узнать больше о доступных продуктах.